HR 4438 · 118th Congress 2023–2025, ended

John W. Walsh Alpha-1 Home Infusion Act of 2023

Latest action · Dec 17, 2024 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJun 30, 2023
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

John W. Walsh Alpha-1 Home Infusion Act of 2023

This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Cosponsors 59

Members who signed on, in the order they did. Signatures ran from Jun 30, 2023 to Oct 1, 2024; 8 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-FLBill PoseyOriginalJun 30, 2023
D-NYBrian HigginsOriginalJun 30, 2023
D-MEChellie PingreeOriginalJun 30, 2023
D-FLDebbie Wasserman SchultzOriginalJun 30, 2023
D-VAGerald E. ConnollyOriginalJun 30, 2023
D-CAJimmy PanettaOriginalJun 30, 2023
D-NYPaul TonkoOriginalJun 30, 2023
D-MAWilliam R. KeatingOriginalJun 30, 2023
D-NCDonald G. DavisJul 14, 2023
D-NCDeborah K. RossJul 27, 2023
R-NEDon BaconAug 11, 2023
R-UTBurgess OwensSep 12, 2023
R-NYAnthony D'EspositoSep 14, 2023
D-PAMadeleine DeanSep 18, 2023
R-NYNicholas A. LangworthySep 18, 2023
D-NYAdriano EspaillatSep 20, 2023
R-NJThomas H. Kean, Jr.Sep 20, 2023
R-PABrian K. FitzpatrickOct 10, 2023
D-NJBill Pascrell, Jr.Oct 13, 2023
D-CADoris O. MatsuiOct 24, 2023
R-NYNick LaLotaOct 24, 2023
D-CAAmi BeraOct 25, 2023
R-NEAdrian SmithOct 26, 2023
D-CARaul RuizNov 2, 2023
D-NJMikie SherrillNov 3, 2023
D-LATroy A. CarterNov 9, 2023
D-COJason CrowNov 21, 2023
D-NJJefferson Van DrewNov 28, 2023
D-NJJosh GottheimerNov 29, 2023
D-CAMike ThompsonNov 30, 2023
D-NJAndy KimDec 1, 2023
D-CAScott H. PetersDec 1, 2023
D-COYadira CaraveoDec 1, 2023
D-NCAlma S. AdamsJan 11, 2024
R-NJChristopher H. SmithJan 12, 2024
D-MNAngie CraigJan 17, 2024
D-CTJohn B. LarsonJan 17, 2024
R-UTCeleste MaloyJan 18, 2024
D-NCJeff JacksonJan 29, 2024
D-NCWiley NickelFeb 1, 2024
R-MNBrad FinstadMar 8, 2024
R-NYNicole MalliotakisMar 15, 2024
R-NYBrandon WilliamsMar 19, 2024
R-NYMichael LawlerMar 19, 2024
R-CADavid G. ValadaoApr 9, 2024
R-CAYoung KimApr 12, 2024
R-ALMike RogersMay 2, 2024
R-FLGus M. BilirakisMay 8, 2024
R-PRJenniffer González-ColónMay 8, 2024
D-FLJared MoskowitzMay 10, 2024
R-NCPatrick T. McHenryMay 22, 2024
D-NCValerie P. FousheeMay 22, 2024
R-NYAndrew R. GarbarinoJun 7, 2024
R-NCDavid RouzerJun 7, 2024
R-FLJohn H. RutherfordJun 26, 2024
R-NCRichard HudsonJul 8, 2024
D-NYTimothy M. KennedyJul 22, 2024
D-CAJohn GaramendiSep 18, 2024
D-MNDean PhillipsOct 1, 2024

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Jun 30, 2023Referred Jun 30, 2023
Health Subcommittee
Referred Jul 7, 2023
HouseWays and Means Committee
Jun 30, 2023Referred Jun 30, 2023
Health Subcommittee
Referred Dec 17, 2024

Actions 4

Everything that happened, newest first.

  1. Dec 17, 2024Referred to the Subcommittee on Health.
  2. Jul 7, 2023Referred to the Subcommittee on Health.
  3. Jun 30, 2023Introduced in House
  4. Jun 30, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 18 The single subject of this legislation is: Rare diseases

The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 114, June 30, 2023, page H3162.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title XVIII of the Social Security Act to provide for coverage and payment of Alpha-1 Antitrypsin Deficiency Disorder treatment under part B of such title, and for other purposes.
Short Title(s) as Introduced
John W. Walsh Alpha-1 Home Infusion Act of 2023

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jun 30, 2023Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.